Takeda Pharmaceutical Non-GAAP EPS of ¥308. 00, revenue of ¥2407B; upgrades FY 2026 outlook

This story focuses on Takeda Pharmaceutical Non-GAAP EPS of ¥308. 00, revenue of ¥2407B; upgrades FY 2026 outlook.